Commonwealth Equity Services’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-19,898
| Closed | -$3K | – | 2748 |
|
|
2018
Q4 | $3K | Buy |
19,898
+6,438
| +48% | +$971 | ﹤0.01% | 2669 |
|
|
2018
Q3 | $6K | Buy |
13,460
+1,600
| +13% | +$713 | ﹤0.01% | 2781 |
|
|
2018
Q2 | $6K | Sell |
11,860
-8,085
| -41% | -$4.09K | ﹤0.01% | 2756 |
|
|
2018
Q1 | $46K | Sell |
19,945
-644
| -3% | -$1.49K | ﹤0.01% | 2597 |
|
|
2017
Q4 | $58K | Buy |
20,589
+8,401
| +69% | +$23.7K | ﹤0.01% | 2558 |
|
|
2017
Q3 | $35K | Sell |
12,188
-9,905
| -45% | -$28.4K | ﹤0.01% | 2487 |
|
|
2017
Q2 | $55K | Buy |
22,093
+10,070
| +84% | +$25.1K | ﹤0.01% | 2411 |
|
|
2017
Q1 | $43K | Buy |
+12,023
| New | +$43K | ﹤0.01% | 2333 |
|
|
2015
Q2 | – | Sell |
-10,629
| Closed | -$296K | – | 2205 |
|
|
2015
Q1 | $296K | Buy |
+10,629
| New | +$296K | ﹤0.01% | 1648 |
|
|
2014
Q3 | – | Sell |
-67,581
| Closed | -$1.1M | – | 2101 |
|
|
2014
Q2 | $1.1M | Buy |
67,581
+38,791
| +135% | +$633K | 0.01% | 812 |
|
|
2014
Q1 | $509K | Buy |
28,790
+20,403
| +243% | +$361K | 0.01% | 1151 |
|
|
2013
Q4 | $203K | Buy |
+8,387
| New | +$203K | ﹤0.01% | 1689 |
|